The evolution of low-dose diuretic therapy: The lessons from clinical trials

American Journal of Medicine

Volumn 101, Issue 3 A, 1996, Pages 47S-52S

  Black, Henry R ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CHLOROTHIAZIDE; CLONIDINE; DILTIAZEM; ENALAPRIL; GUANABENZ; GUANETHIDINE; HEXAMETHONIUM; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOSARTAN; MECAMYLAMINE; METHYLDOPA; MINOXIDIL; NIFEDIPINE; PRAZOSIN; RESERPINE; VERAPAMIL; BENZOTHIADIAZINE DERIVATIVE; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; CLINICAL PROTOCOL; DIURETIC THERAPY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; TREATMENT PLANNING; WEIGHT REDUCTION; CLINICAL TRIAL; PRACTICE GUIDELINE;

BENZOTHIADIAZINES; CLINICAL TRIALS; DIURETICS; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0030607039     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00267-7     Document Type: Review

References (29)

1. Hollander W, Wilkins R. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. Boston Medical Quarterly. 1957;8:65-75.
2. Report on the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. A Cooperative Study. JAMA. 1977;237:255-261.
3. The Joint National Committee on Detection, Evaluation and Treatment on High Blood Pressure. The 1980 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1980;140:1280-1285.
4. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1984;144:1045-1057.
5. 1988 Joint National Committee. The 1988 Report on the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
6. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 1993;153:154-183.
7. Materson BJ, Oster JR, Michael UF, et al. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther. 1978;24:192-198.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. JAMA. 1982;248:1996-2003.
9. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for treatment of hypertension. II. Results of long-term therapy. JAMA. 1982;248:2004-2011.
10. Hill MN, Levine DM, Whelton PK. Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health. 1988;78:1190-1194.
11. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562-2571.
12. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. JAMA. 1979;242:2572-2577.
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;266:3255-3264.
14. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
15. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J. 1992;304:405-412.
16. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment morbidity in hypertension: 1. Results in patient with diastolic blood pressure averages 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
17. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on Morbidity in Hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143-1152.
18. US Public Health Services Hospital Cooperative Study Group. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res. 1977;40(suppl 1):I-98-I-105.
19. Australian National Blood Pressure Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet. 1980;i:1261-1267.
20. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;i:1349-1354.
21. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Intervention Trial. JAMA. 1982;248:1465-1472.
22. Whelton PK, Watson AJ. Diuretic-induced hypokalemia and cardiac arrhymias. Am J Cardiol. 1986;58(suppl):5A-10A.
23. Kuller LH, Hulley SB, Cohen JD, Neaton J. Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation. 1987;73:114-123.
24. The Hypertension Detection and Follow-up Cooperative Research Group. The effect of anti-hypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline. Circulation. 1984;70:996-1003.
25. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Compass MK, Wagner EH. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994;330:1852-1857.
26. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black HB, Camel G, Davis BR, Frost PH, Gonzales N, Guthrie G, Oberrnan A, Rutan G, Stamler J, for the SHEP Cooperative Research Group. Low dose diuretic-based anti-hypertensive treatment reduces cardiovascular disease risks in older diabetics with isolated systolic hypertension. (Submitted).
27. Neaton JD, Grimm RHJ, Prineas RJ, et al. Treatment of mild hypertension study (TOMHS): final results. JAMA. 1993;270:713-724.
28. Materson BJ, Reda DJ, Cushman WC, et al. Single drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
29. Materson BJ, Reda DJ, Cushman WC, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Anti-Hypertensive Agents. Results of combination anti-hypertensive therapy after failure of each of the components. J Hum Hyp. 1995;9:791-796.